Magnetar Financial LLC

Position in NVO — Novo Nordisk A S

CIK 1352851 EVANSTON, IL

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$296,604

+$79,890 QoQ

Shares Held

6,187

+4.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#898

of 1,348 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Magnetar Financial LLC holds $42,185,710 across 4 Drug Manufacturers - General names. NVO ranks #4 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OGN	Organon & Co.	2,810,019	$38,047,656
2	LLY	ELI LILLY & Co	1,790	$2,146,979
3	GILD	Gilead Sciences, Inc.	13,412	$1,694,471
4	NVO	Novo Nordisk A S This page	6,187	$296,604

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$296,604	6,187	+4.9%	Shares	Sole	2026-08-14
2026-03-31	$216,714	5,897	-98.2%	Shares	Sole	2026-05-13
2024-09-30	$39,694,008	333,367	+225.3%	Shares	Sole	2024-11-13
2024-06-30	$14,629,708	102,492	-40.1%	Shares	Sole	2024-08-14
2024-03-31	$21,959,096	171,021	+66.8%	Shares	Sole	2024-05-15
2022-12-31	$13,877,898	102,541	-65.7%	Shares	Sole	2023-02-14
2022-09-30	$29,793,355	299,040	-37.8%	Shares	Sole	2022-11-14
2022-06-30	$53,561,726	480,676	+33.2%	Shares	Sole	2022-08-15
2022-03-31	$40,061,065	360,748	+25.2%	Shares	Sole	2022-05-16
2021-12-31	$32,261,824	288,052	+155.1%	Shares	Sole	2022-02-14
2021-09-30	$10,841,353	112,919	+156.6%	Shares	Sole	2022-01-14
2020-03-31	$2,648,800	44,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.